Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 14, 2003

View Archived Issues

New antidiabetic agents discovered at Toray

Antibacterial PDF inhibitors prepared and tested at Senju

Novel 5-HT4 ligands and their use in gastrointestinal disorders

BMS and Pharmacopeia jointly report new p38 kinase inhibitors

Abbott claims selective dopamine D3 modulators for use in psychoses and other disorders

Wyeth researchers identify new EAAT2 inhibitors with potential in schizophrenia

New COX-2 inhibitors covered by Pfizer patents

Basiliximab immunoprophylaxis in the prevention of acute rejection after renal transplantation

Liposomal doxorubicin combined with IL-12 synergistic in HIV-associated KS

Clinical safety and pharmacokinetics of UK-427857 in healthy volunteers

Good safety profile of the IL-2 agonist Bay-50-4798 in cynomolgus monkeys

Viral load reduction with tipranavir/ritonavir related to trough tipranavir plasma levels

diaDexus licenses rights to testisin cancer target

Telik and Vanderbilt-Ingram Cancer Center sign agreement for cancer drug discovery

Ribozyme to secure financing to support development of RNAi therapeutics

Bayer seeks expansion of aspirin labeling to include prevention of first heart attack

Renovis awarded grant to support psychiatric drug discovery

Synaptic shareholders approve merger with Lundbeck

Altus and Dr. Falk form alliance to develop TheraCLEC in Europe

BCY LifeSciences updates status of phase II DCF-987 trial in cystic fibrosis

Avanir generates antibody to neutralize anthrax toxin

AlgoRx acquires rights to novel antimigraine therapy

Effexor XR approved for social anxiety disorder

Targeted intracellular drug delivery demonstrated by Cyclosert

Novel vitamin D analogue with dissociation between immunosuppressive and hypercalcemic effects

Benzophenone NNRTIs characterized in vitro at GSK

Ro-033-4649 holds promise for protease inhibitor-resistant HIV infection

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...